CareteqASX:CTQ Pretax Margin % is -1,807.84% as of Dec. 2025. The stock has 8 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Careteq ranks worse than 83.18% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Careteq's Pre-Tax Income for the
six
months ended in Dec. 2025 was A$-0.92 Mil. Careteq's Revenue for the
six
months ended in Dec. 2025 was A$0.05 Mil. Therefore, Careteq's pretax margin for the quarter that ended in Dec. 2025 was -1,807.84%.
The historical rank and industry rank for Careteq's Pretax Margin % or its related term are showing as below:
ASX:CTQ'
s Pretax Margin % Range Over the Past 10 Years
Min: -118.56 Med: -45.44 Max: -4.46
Current: -32.55
ASX:CTQ's Pretax Margin % is ranked worse than 83.18% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 4.01
vs ASX:CTQ: -32.55
Careteq (ASX:CTQ) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Careteq Pretax Margin % Related Terms
Careteq Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Careteq's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:CTQ vs VEEV, BTSG, TEM: Pretax Margin % Comparison
For the Health Information Services subindustry, Careteq's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Careteq Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Careteq's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Careteq's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Careteq (ASX:CTQ) has a Pretax Margin % of -1,807.84% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Careteq and its competitors. According to the industry distribution chart, Careteq ranks #554 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 83.2%.
Is Careteq's Pretax Margin % too high?
Careteq's current Pretax Margin % is -1,807.84%. Based on the distribution chart, Careteq ranks #554 out of 666 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Careteq's Pretax Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Careteq ranks #554 out of 666 companies for Pretax Margin %. This places Careteq in the lower half of its industry. The industry median Pretax Margin % is 4.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.01, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Careteq and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Careteq's current Pretax Margin % is -1,807.84%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Careteq stock overvalued right now?
Based on GuruFocus' analysis, Careteq (ASX:CTQ) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 20% above its estimated fair value. The current Pretax Margin % is -1,807.84%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Careteq (ASX:CTQ), the current Pretax Margin % is -1,807.84% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Careteq Ltd provides Residential Medication Management Review and Home Medicines Review services as part of the Medication Management Programs, generating revenue from medication review, education, and support services. The company focuses on medication management and home care solutions to provide continuity of care and improve clinical outcomes for patients through Home Medication Reviews. Medication-related harm includes adverse drug reactions, medication errors, and complications that jeopardise patient safety and increase healthcare costs. The company operates in Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CTQ has been successfully added to your 